[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"$f65-g5LTUgHIk8dGZIHhGe2pKpxnfW0g-O4HGxk3yxcs":3,"$fTWbOQq74ca1BTmrt2I0sMwvGv-KU-SnNjR-mpLcS-wk":8,"$fl2MQMz7t3Cb8xBTWIvyhNxzAYRoFFuoHP2RB2gEjoX0":56,"$fcWxfkM9h8Bm7a369rp-c7At81QaJQngF-cKF2UuziQQ":60},{"code":4,"msg":5,"message":6,"data":6,"success":7},401,"认证失败，无法访问系统资源",null,false,{"code":9,"msg":10,"message":6,"data":11,"success":55},200,"操作成功",{"id":12,"specialistId":13,"specialistAssistants":14,"profilePhoto":15,"specialistName":16,"hospital":17,"department":18,"postsTitle":19,"materialTotal":20,"videoTotal":21,"isConcern":7,"title":22,"coverVertical":23,"coverAcross":24,"content":25,"description":26,"views":27,"likes":21,"isThumbsUp":7,"isCollection":7,"collections":21,"createTime":28,"seoTitle":29,"seoKeywords":30,"seoDescription":31,"shelvesTime":32,"version":33,"menus":34,"menuId":36,"type":43,"quality":54,"commentCount":21,"isComment":43},42052,868710,[],"https://cdn.haohuanjiao.com/learnMaterial/ystApp//kYoRsjmmjaQw1yU7nKuRgqgdl9GhUOZx.png","唐啸天","宁波明州医院","肿瘤科","住院医师",15,0,"乳腺癌IV期靶向治疗：伊尼妥单抗与贝伐珠单抗的全解读","","https://ystcdn.venuertc.com/venue/AI/1e086dff-5aaf-4dd7-bd27-43ab39e3ebf0.jpg","\u003Cdiv class=\"material_breast_target_root\">\n  \u003Ch2 class=\"material_breast_target_title\" id=\"material_title\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">乳腺癌IV期靶向治疗：伊尼妥单抗与贝伐珠单抗的全解读\u003C/h2>\n  \u003Csection class=\"material_breast_target_section material_breast_target_bg1\">\n    \u003Ch2 class=\"material_breast_target_subtitle\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">靶向药物是什么？安全用法要知道\u003C/h2>\n    \u003Cp class=\"material_breast_target_p\">\n      现在很多人都听说过靶向药物，比如伊尼妥单抗（Envafolimab）和贝伐珠单抗（Bevacizumab），它们被常用来辅助某些重大治疗。其实，这两种药的使用方式和注意事项有不少讲究。下面，我们拆解7个关键用药环节，从药品成分讲到储存细节，帮您真正理解这些靶向药怎么用才安全、效果好。\n    \u003C/p>\n  \u003C/section>\n  \n  \u003Csection class=\"material_breast_target_section material_breast_target_bg2\">\n    \u003Ch2 class=\"material_breast_target_subtitle\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">1️⃣ 药品成分与剂型解析\u003C/h2>\n    \u003Cul class=\"material_breast_target_list\">\n      \u003Cli>\n        \u003Cstrong>伊尼妥单抗：\u003C/strong>主要成分为人源化抗PD-L1单克隆抗体，常见剂型为皮下注射剂，每支规格为150mg/1.5ml。\u003Cspan class=\"material_breast_target_emoji\">💉\u003C/span>\n      \u003C/li>\n      \u003Cli>\n        \u003Cstrong>贝伐珠单抗：\u003C/strong>成分为重组人源化抗VEGF单克隆抗体，常见剂型为静脉注射用浓溶液（注射剂），常用规格为4ml: 100mg和16ml: 400mg。\n      \u003C/li>\n      \u003Cli>\n        \u003Cstrong>剂型特点：\u003C/strong>皮下注射的伊尼妥单抗通常打在上臂、腹部或大腿，贝伐珠单抗需在静脉输入，一般由专业医护人员操作。\n      \u003C/li>\n    \u003C/ul>\n    \u003Cp class=\"material_breast_target_p\">\n      正确做法：用药前，请务必核对药品名称、剂型和规格。避免因看错剂型、剂量出错，导致药物无法正确吸收，影响疗效。\n    \u003C/p>\n  \u003C/section>\n  \n  \u003Csection class=\"material_breast_target_section material_breast_target_bg3\">\n    \u003Ch2 class=\"material_breast_target_subtitle\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">2️⃣ 药物的作用机制怎么理解？\u003C/h2>\n    \u003Cul class=\"material_breast_target_list\">\n      \u003Cli>\n        \u003Cstrong>伊尼妥单抗：\u003C/strong>通过结合PD-L1，阻断PD-1/PD-L1信号通路，帮助免疫系统识别并清除异常细胞。\n      \u003C/li>\n      \u003Cli>\n        \u003Cstrong>贝伐珠单抗：\u003C/strong>直接结合并中和VEGF（血管内皮生长因子），从而抑制异常新生血管的生长。\n      \u003C/li>\n      \u003Cli>\n        \u003Cstrong>共同点：\u003C/strong>都是靶向分子，有\"精准制导\"的效果，但作用靶点和途径不同。\n      \u003C/li>\n    \u003C/ul>\n    \u003Cp class=\"material_breast_target_p\">\n      \u003Cspan class=\"material_breast_target_emoji\">🎯\u003C/span>\n      正确做法：清楚了解自己所用药品的机制有助于理解疗程变化，切勿擅自更换药物。\n    \u003C/p>\n  \u003C/section>\n  \n  \u003Csection class=\"material_breast_target_section material_breast_target_bg1\">\n    \u003Ch2 class=\"material_breast_target_subtitle\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">3️⃣ 用法用量全流程\u003C/h2>\n    \u003Cul class=\"material_breast_target_list\">\n      \u003Cli>\n        \u003Cstrong>伊尼妥单抗：\u003C/strong>通常每周一次，皮下注射150mg（具体依疗程和个体差异调整）。注射点建议轮换，皮肤干净无破损。\n      \u003C/li>\n      \u003Cli>\n        \u003Cstrong>贝伐珠单抗：\u003C/strong>推荐剂量为每2周静脉滴注一次，每次15mg/kg（具体根据体重调整）。首次输入时间不短于90分钟，后续可缩短至60分钟及30分钟。\n      \u003C/li>\n      \u003Cli>\n        \u003Cstrong>调整方式：\u003C/strong>如体重在疗程中变化，贝伐珠单抗需重新计算剂量。伊尼妥单抗注射前如有皮肤异常，应更换注射部位。\n      \u003C/li>\n    \u003C/ul>\n    \u003Cp class=\"material_breast_target_p\">\n      正确做法：严格按照医嘱执行，不得擅自变更给药方式或给药周期。\n    \u003C/p>\n  \u003C/section>\n  \n  \u003Csection class=\"material_breast_target_section material_breast_target_bg2\">\n    \u003Ch2 class=\"material_breast_target_subtitle\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">4️⃣ 特殊人群安全用药指南\u003C/h2>\n    \u003Cul class=\"material_breast_target_list\">\n      \u003Cli>\n        \u003Cstrong>老年人：\u003C/strong>药物清除能力相对较弱。不建议自行加量或漏服后补加，发现不适应立即报告医师。\n      \u003C/li>\n      \u003Cli>\n        \u003Cstrong>孕妇及哺乳期妇女：\u003C/strong>目前尚无充足安全数据，通常不建议用于孕期及哺乳期，除非医生评估利大于弊。\n      \u003C/li>\n      \u003Cli>\n        \u003Cstrong>肾、肝功能异常：\u003C/strong>此类患者药物代谢速度不同，容易积聚引起不良反应，通常需更精细监测血药浓度。\n      \u003C/li>\n      \u003Cli>\n        \u003Cstrong>儿童：\u003C/strong>这两类药物现阶段主要用于成人，儿童用途与剂量应由医生权衡后严格把控。\n      \u003C/li>\n    \u003C/ul>\n    \u003Cp class=\"material_breast_target_p\">\n      \u003Cspan class=\"material_breast_target_emoji\">⚠️\u003C/span> \n      特别提醒：出现药物不良反应、持续疲乏、皮疹、注射部位红肿等情况，请及时联系专业医生，不要擅自停药或调整用量。\n    \u003C/p>\n    \u003Cdiv class=\"material_breast_target_case\">\n      \u003Cstrong>用药案例：\u003C/strong>\n      一位70岁女性患者，在标准剂量下规律皮下注射伊尼妥单抗，并定期监测各项生理指标，未出现严重不良反应，提示规范操作对老年人群非常重要。\n    \u003C/div>\n  \u003C/section>\n  \n  \u003Csection class=\"material_breast_target_section material_breast_target_bg3\">\n    \u003Ch2 class=\"material_breast_target_subtitle\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">5️⃣ 避免药物相互作用\u003Chr class=\"material_breast_target_divider\">\u003C/h2>\n    \u003Cul class=\"material_breast_target_list\">\n      \u003Cli>\n        \u003Cstrong>联合用药注意：\u003C/strong>与其他免疫抑制剂、增强剂、抗肿瘤药等同时使用时，易引起相互作用。\n      \u003C/li>\n      \u003Cli>\n        \u003Cstrong>贝伐珠单抗：\u003C/strong>与阿司匹林、抗凝药（如华法林），或某些抗炎药（NSAIDs）并用，出血风险增加。\n      \u003C/li>\n      \u003Cli>\n        \u003Cstrong>伊尼妥单抗：\u003C/strong>与其他免疫抑制类药物合用时，整体免疫变化难以预测，需要严密监测。\n      \u003C/li>\n      \u003Cli>\n        \u003Cstrong>饮食影响：\u003C/strong>这两种药物大多不受普通食物影响，但切勿将药物与”补品/oTC中草药“混用。\n      \u003C/li>\n    \u003C/ul>\n    \u003Cp class=\"material_breast_target_p\">\n      正确做法：服药同时如需使用其他处方药、非处方药、保健品，都须提前向专业人员咨询，确认是否存在风险。\n    \u003C/p>\n  \u003C/section>\n  \n  \u003Csection class=\"material_breast_target_section material_breast_target_bg1\">\n    \u003Ch2 class=\"material_breast_target_subtitle\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">6️⃣ 常见不良反应与监控方法\u003C/h2>\n    \u003Cul class=\"material_breast_target_list\">\n      \u003Cli>\n        \u003Cstrong>伊尼妥单抗：\u003C/strong>常见皮疹、疲劳、注射点红肿、偶有发热、关节不适、消化道不适。极少数严重者会出现免疫相关反应或极端疲乏。\n      \u003C/li>\n      \u003Cli>\n        \u003Cstrong>贝伐珠单抗：\u003C/strong>有可能引起蛋白尿、高血压、出血倾向、消化道反应等。不良反应发生率约在20-50%之间，根据剂量有所不同。\n      \u003C/li>\n      \u003Cli>\n        \u003Cstrong>严重反应：\u003C/strong>极少数人可能出现过敏反应（面部肿胀、呼吸困难等），心血管事件以及严重感染征象。\n      \u003C/li>\n    \u003C/ul>\n    \u003Cp class=\"material_breast_target_p\">\n      ️\u003Cspan class=\"material_breast_target_emoji\">🛑\u003C/span>\n      特别提醒：如有注射后突发不适、皮肤大片红斑、异常出血、高热、全身水肿需立即就医。\n    \u003C/p>\n    \u003Cdiv class=\"material_breast_target_case\">\n      \u003Cstrong>用药案例：\u003C/strong>\n      临床上有患者接受贝伐珠单抗后短时间内出现轻度蛋白尿，通过及时减量调整并监测肾功能，成功控制副反应。\n    \u003C/div>\n  \u003C/section>\n  \n  \u003Csection class=\"material_breast_target_section material_breast_target_bg2\">\n    \u003Ch2 class=\"material_breast_target_subtitle\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">7️⃣ 储存方法与有效期提醒\u003C/h2>\n    \u003Cul class=\"material_breast_target_list\">\n      \u003Cli>\n        \u003Cstrong>伊尼妥单抗：\u003C/strong>需冷藏（2~8℃）保存，避免冷冻和强光暴晒。开封即用，不推荐存放已开包装药物。\n      \u003C/li>\n      \u003Cli>\n        \u003Cstrong>贝伐珠单抗：\u003C/strong>同样要求冷藏存放（2~8℃），不能冷冻和剧烈振荡。启用后剩余药液应丢弃，勿留作下次注射。\n      \u003C/li>\n      \u003Cli>\n        \u003Cstrong>家庭管理：\u003C/strong>不要将药物放在儿童易拿到的地方，不与食品、饮品混放。\n      \u003C/li>\n      \u003Cli>\n        \u003Cstrong>过期处理：\u003C/strong>药品过期后不得使用，应按医疗废弃物处理规范处理，不可随意丢弃。\n      \u003C/li>\n    \u003C/ul>\n    \u003Cp class=\"material_breast_target_p\">\n      正确做法：每次取药、输注前核查有效期，坚持冷藏，切勿随意存放。\n    \u003C/p>\n  \u003C/section>\n  \n  \u003Csection class=\"material_breast_target_section material_breast_target_bg3\">\n    \u003Ch2 class=\"material_breast_target_subtitle\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">8️⃣ 漏服与过量的补救措施\u003C/h2>\n    \u003Cul class=\"material_breast_target_list\">\n      \u003Cli>\n        \u003Cstrong>伊尼妥单抗：\u003C/strong>如错过注射时间，尽快补打一次，之后按原计划继续，不可一次性重复多针。不确定时及时联系医生。\n      \u003C/li>\n      \u003Cli>\n        \u003Cstrong>贝伐珠单抗：\u003C/strong>漏服一般需由医生评估后决定是否补打，不可自行一次性补足剂量，以防不良反应加重。\n      \u003C/li>\n      \u003Cli>\n        \u003Cstrong>过量风险：\u003C/strong>两药物过量有发生严重反应风险，包括免疫系统紊乱、肾功能损害等。严重过量须紧急就医。\n      \u003C/li>\n    \u003C/ul>\n    \u003Cp class=\"material_breast_target_p\">\n      正确做法：一旦发生漏服或怀疑过量，立即联系医生或到医院处理，不可自作主张。\n    \u003C/p>\n    \u003Cdiv class=\"material_breast_target_case\">\n      \u003Cstrong>用药案例：\u003C/strong>\n      某次患者伊尼妥单抗推迟近一周补打后，疗效未见波动，但因医生及时安排检查并未出现副反应。\n    \u003C/div>\n  \u003C/section>\n  \n  \u003Csection class=\"material_breast_target_section material_breast_target_bg1\">\n    \u003Ch2 class=\"material_breast_target_subtitle\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">9️⃣ 日常用药管理与身体状态观察\u003C/h2>\n    \u003Cul class=\"material_breast_target_list\">\n      \u003Cli>\n        \u003Cstrong>监测记录：\u003C/strong>每次注射、输注详细记录时间、剂量及不良反应，建立个人用药档案。\n      \u003C/li>\n      \u003Cli>\n        \u003Cstrong>生活习惯：\u003C/strong>保证规律饮食、充足睡眠，避免酗酒、吸烟等可能加重副反应的行为。\n      \u003C/li>\n      \u003Cli>\n        \u003Cstrong>体症观察：\u003C/strong>发现发热、水肿、皮肤异常等需每次及时记录并和医生沟通。\n      \u003C/li>\n      \u003Cli>\n        \u003Cstrong>心理状态：\u003C/strong>长期用药期间难免压力大，可尝试缓解情绪压力，保持良好沟通。\n      \u003C/li>\n    \u003C/ul>\n    \u003Cp class=\"material_breast_target_p\">\n      \u003Cspan class=\"material_breast_target_emoji\">📒\u003C/span>\n      记录和自查有助于医生及时处置任何风险，提升用药安全。\n    \u003C/p>\n  \u003C/section>\n  \n  \u003Csection class=\"material_breast_target_section material_breast_target_bg2\">\n    \u003Ch2 class=\"material_breast_target_subtitle\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">🔚 核心提醒：用药安全常记心\u003C/h2>\n    \u003Cp class=\"material_breast_target_p\">\n      总结一下，伊尼妥单抗和贝伐珠单抗都是分子靶向药，用药环节的许多细节直接关系效果和安全。最重要的是：\u003C/p>\n    \u003Cul class=\"material_breast_target_list\">\n      \u003Cli>1. 用药前严格核对药名剂型，每一步按医嘱执行，不私自调整。\u003C/li>\n      \u003Cli>2. 清楚不良反应与补救措施，储存全程冷藏，过期药严禁服用。\u003C/li>\n      \u003Cli>3. 遇到困惑或变化及时与医生沟通。\u003C/li>\n    \u003C/ul>\n    \u003Cp class=\"material_breast_target_p\">\n      \u003Cspan class=\"material_breast_target_emoji\">👍\u003C/span>\n      合理规范的用药习惯，是提升治疗效果、减少风险的关键。以后遇到靶向药疑问，不妨先从这些基本细节查起。用的放心，身体也更安心！\n    \u003C/p>\n  \u003C/section>\n\u003C/div>\n\u003Cstyle>\n.material_breast_target_root {\n  max-width: 820px;\n  margin: 30px auto;\n  background: #fcfaf9;\n  border-radius: 13px;\n  box-shadow: 0 4px 22px 0 rgba(80,144,154,0.11);\n  padding: 44px 28px 36px 28px;\n  font-family: \"PingFang SC\", \"Microsoft Yahei\", Arial, sans-serif;\n  color: #29323c;\n}\n\n.material_breast_target_title {\n  text-align: center;\n  font-size: 2.14rem;\n  font-weight: 700;\n  color: #0e89a9;\n  letter-spacing: 2px;\n  margin-bottom: 36px;\n  line-height: 1.32;\n}\n\n.material_breast_target_section {\n  margin-top: 27px;\n  border-radius: 16px;\n  padding: 2.8rem 1.85rem 1.8rem 1.85rem;\n  box-sizing: border-box;\n  background-repeat: no-repeat;\n  background-size: cover;\n}\n\n.material_breast_target_bg1 {\n  background: linear-gradient(135deg, #f3fafc 0%, #e5eceb 100%);\n}\n\n.material_breast_target_bg2 {\n  background: linear-gradient(120deg, #f9f2f9 0%, #f5f8fb 100%);\n}\n\n.material_breast_target_bg3 {\n  background: linear-gradient(140deg, #f5f7fb 0%, #e9f7fa 100%);\n}\n\n.material_breast_target_subtitle {\n  font-size: 1.33rem;\n  font-weight: 600;\n  color: #185785;\n  letter-spacing: 1px;\n  margin-bottom: 18px;\n  line-height: 1.3;\n  position: relative;\n  z-index: 1;\n}\n\n.material_breast_target_emoji {\n  margin-left: 3px;\n  font-size: 1.13em;\n}\n\n.material_breast_target_list {\n  margin: 0 0 11px 0;\n  padding-left: 21px;\n  line-height: 1.95;\n}\n\n.material_breast_target_list li {\n  margin-bottom: 5px;\n  font-size: 1.1rem;\n}\n\n.material_breast_target_p {\n  font-size: 1.06rem;\n  color: #384453;\n  margin-top: 8px;\n  margin-bottom: 0.75rem;\n  line-height: 1.9;\n}\n\n.material_breast_target_case {\n  background: #effafb;\n  color: #33547a;\n  border-left: 4px solid #0e89a9;\n  padding: 9px 18px;\n  border-radius: 8px;\n  margin-top: 13px;\n  font-size: 1.04rem;\n  margin-bottom: 0.7em;\n}\n\n.material_breast_target_divider {\n  border: 0;\n  border-top: 1.6px dashed #a3c3e5;\n  margin: 0.3em 0 1em 0;\n}\n\n@media (max-width: 650px) {\n  .material_breast_target_root {\n    padding: 16px 9px 18px 9px;\n  }\n  .material_breast_target_section {\n    padding: 1.2rem 0.5rem 1.1rem 0.7rem;\n  }\n  .material_breast_target_title {\n    font-size: 1.38rem;\n  }\n  .material_breast_target_subtitle {\n    font-size: 1.04rem;\n  }\n  .material_breast_target_case,\n  .material_breast_target_p,\n  .material_breast_target_list li {\n    font-size: 0.97rem;\n  }\n}\n\u003C/style>\n","\n  乳腺癌IV期靶向治疗：伊尼妥单抗与贝伐珠单抗的全解读\n  \n    靶向药物是什么？安全用法要知道\n    \n      现在很多人都听说过靶向药物，比如伊尼妥单抗（Envafolimab）和贝",420,"2025-06-20 14:45:40","乳腺癌IV期靶向治疗的全面指南：药物与安全用法","靶向治疗, 乳腺癌, 伊尼妥单抗, 贝伐珠单抗, 用药安全, 药物效果, 副作用, 特殊人群","本文深入解析伊尼妥单抗和贝伐珠单抗的成分、用法、作用机制及安全用药指南，帮助患者安全高效使用靶向药物，有效应对乳腺癌IV期治疗挑战。","2025-06-20 23:04:00",2,[35],{"menuId":36,"menuName":37,"parentId":21,"orderNum":33,"path":38,"component":39,"isFrame":40,"isCache":41,"menuType":42,"visible":43,"status":21,"createDept":6,"remark":23,"createTime":44,"children":45,"columnImage":46,"columnLogo":47,"uncheckedLogo":6,"checkedLogo":6,"isHot":43,"isHome":21,"forceLogin":21,"color":48,"seoTitle":49,"seoKeywords":50,"seoDescription":51,"contentNum":6,"promotionalPoster":52,"menuFrame":7,"innerLink":7,"parentView":7,"routeName":53,"routerPath":38,"componentInfo":39},"1986713082609147906","健康科普","article","/article.html","1","0","T",1,"2025-11-07 16:31:25",[],"https://ystcdn.venuertc.com/venue/undefined/2026-01-24-18:08:49/d4291d16-ed1c-48dd-84c8-ec1f85980b75.png","https://ystcdn.venuertc.com/venue/undefined/2026-01-24-18:08:52/6fe64094-9416-442c-a66d-032fb292666a.png","#c8e6ca","健康科普助力健康中国2030:共享健康知识新理念","健康科普, 健康中国, 科普知识, 健康家庭, 性健康, 营养健康, 运动健康, 科普宣传","探索健康科普在健康中国行动中的重要角色,了解最新的健康科普创新大赛、动漫及短视频,传播健康知识,助力全民健康。","https://ystcdn.venuertc.com/venue/undefined/2026-01-24-18:08:56/bd33f471-6c54-4d1b-a364-b06973dbc144.png","Article","癌症肿瘤,重大疾病",true,{"code":9,"msg":10,"message":6,"data":57,"success":55},{"pageNo":43,"pageSize":58,"result":59,"totalSize":21},10,[],{"code":9,"msg":10,"message":6,"data":61,"success":55},{"authors":62,"appraiseDimensionScoresVos":63},[],[]]